SÃO PAULO, SP (FOLHAPRESS) - O ministro da Defesa israelense, Israel Katz, disse nesta terça-feira (23) que os militares de seu país nunca deixariam a Faixa de Gaza completamente e que planejavam ...
Gang of Dragon foi oficialmente revelado no dia 11 de dezembro durante o The Game Awards, marcando o primeiro jogo da Nagoshi Studio — estúdio fundado por Toshihiro Nagoshi, criador da franquia Yakuza ...
Novo Nordisk, which has stumbled through a bit of a manufacturing hangover at a former Catalent production site it picked up a year ago, was hit with a warning letter from the FDA last month. The ...
Novo Nordisk first to market with Wegovy pill Analysts see potential but question if pills are a 'game changer' Advantage for Novo could be short-lived, analysts say The approval of Novo's Wegovy pill ...
When Novo Nordisk launched Wegovy, its pioneering weight-loss jab, in America in June 2021, it felt like it was “running into a dark tunnel”, recalls Maziar Mike Doustdar, who took over as the Danish ...
The U.S. Food and Drug Administration on Dec. 22 approved a pill version of Novo Nordisk’s weight-loss drug Wegovy, the first daily oral medication for obesity treatment. The once-daily tablet — ...
O ano já está acabando e, com isso, está aberta a época de confraternizações e celebrações com a família, fazendo com que renovar votos de esperança e afeto se torne quase um ritual. E para ajudar ...
Dec 18 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab said on Thursday it had filed a marketing application with the U.S. Food and Drug Administration for CagriSema, its once-weekly ...
These two healthcare stocks are top names to invest in, but they haven't both been doing well of late. Eli Lilly has generated $25 billion in revenue from its fast-growing GLP-1 drugs this year. Novo ...
The pole position in the GLP-1 weight loss space is currently held by Eli Lilly. Novo Nordisk was the early leader, showing that being first doesn't always mean you stay at the head of the pack.
Novo Nordisk wins FDA approval for Wegovy in a pill, introducing first oral GLP-1 option for obesity
After ushering in a new era of obesity treatment with its GLP-1 medicine Wegovy earlier in the decade, Novo Nordisk is making history again with the first FDA approval of a GLP-1 pill for weight loss.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback